Main Library

Implement Pharmacy Performance Measures for Value-Based Care

April 11, 2022Micah Cost, PharmD, MSPharmacy TimesPharmacy Services,Quality Measures

The Pharmacy Quality Alliance (PQA) has a new pharmacy performance measure that evaluates adherence to medications for diabetes, renin angiotensin system antagonists for hypertension, and statins for high cholesterol through a single composite measure. Although many might think the PQA already had member-endorsed adherence measures for these medications, the situation is a bit nuanced.

There are 3 similar PQA adherence measures used in the Medicare Part D Star Ratings that were developed, tested, and specified for health plan performance measurement. There are notable differences between those health plan measures and the PQA’s new pharmacy measure. Endorsed by PQA members after rigorous development and testing, the new composite pharmacy adherence measure is a major step forward in the PQA’s work to develop standard pharmacy performance measures focused on improving patient care.

Full Article

: Pharmacy

Related Posts

Building a Value-Based Pharmacy Performance Program

November 15, 2021Garrett Schmitt

3 Innovative Programs of Highly Successful ACOs

July 16, 2017aco

How Pharmacists Can Help Address Social Determinants of Health

January 18, 2022aco

Recent Posts

  • Medicare Advantage Advance Notice: Who Will be Impacted, and How?
  • Mastering Seasonal Scheduling to Achieve Higher Quality Outcomes
  • Food Security: Key Dimensions of the Social Determinant of Health
  • RECORDED WEBINAR: How to Prepare for Market Changes to Health Equity and Social Determinants of Health
  • RECORDED WEBINAR: How Innovative Digital Trends are Revolutionizing ACO Outcomes
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us